Search

everythinglearnresearchcommunity

for

Search:↓

Localized dystrophic epidermolysis bullosa (DEB) can lead to scarring alopecia, highlighting the need to recognize and address this complication.

The study suggests that changes in immune system receptors and their interaction with a cell component may be important in the development of a type of hair loss condition.

Scarring alopecia, a type of hair loss, is most common in females under 35, often caused by discoid lupus erythematosus and pseudopelade of Brocq. Skin punch biopsy and histopathology are key to identifying its cause.

More research is needed to confirm PRP's effectiveness for scarring alopecia.

Chemical relaxers may cause scarring alopecia in black women.

The text talks about a rare skin condition causing hair loss and suggests that people with this should also check their lung and heart health.

Postmenopausal frontal fibrosing alopecia may be a unique condition linked to postmenopausal changes.

Erlotinib may cause scarring hair loss.

Psychological interventions can improve mental health and quality of life in people with alopecia.

Hair relaxers can cause lasting scalp damage and hair loss.

Using CD123 to detect certain immune cells helps diagnose a type of hair loss condition.

A 12-year-old boy's hair loss and skin issues improved significantly with medication.

The man's scarring alopecia and skin issues did not improve with treatments.

A woman with scalp lymphoma and hair loss improved with radiotherapy, highlighting the need for biopsies in similar cases.

Hair loss can be caused by various factors, and treatments focus on restoring normal hair growth.

Targeting JAK-STAT1 can reduce inflammation and promote hair growth in conditions linked to EGFR deficiency.

Mesotherapy for the scalp can cause severe infections, fat tissue death, and permanent hair loss.

Sarcoidosis can cause severe high calcium levels, hair loss, and kidney failure.

Combining Ficlatuzumab and Gefitinib can cause severe hair loss.

Deucravacitinib helped regrow hair and reduce plaques in a woman with discoid lupus erythematosus without side effects.

LC-OCT can help identify lupus-related scarring hair loss by spotting unique features.

Dense-packing follicular unit extraction is a safe and effective way to treat extensive scarring alopecia.

Early diagnosis and treatment are crucial to prevent permanent hair loss from TNFα inhibitors in scalp psoriasis.

Fat grafting before hair transplant may improve hair growth in scarring alopecia.

Kikuchi–Fujimoto disease can cause scarring alopecia and should be considered in diagnosis.

LC-OCT can help diagnose different types of scarring alopecia.

Untreated epidermolysis bullosa acquisita can cause total hair and nail loss.

Topical calcineurin inhibitors might be safer than steroids for scarring alopecia, but more research is needed.

A child had a rare case of scarring hair loss with skin disease, which is hard to treat and stressful.